Literature DB >> 16304342

Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep.

Juan R Sabater1, Troy A Lee, William M Abraham.   

Abstract

STUDY
OBJECTIVE: We measured tracheal mucus velocity (TMV), a marker of mucociliary clearance (MCC), in sheep before and for 12 h after treatment with salmeterol, albuterol, ipratropium, or vehicle to determine the effects on normal MCC. We also determined if these agents could reverse the depression in TMV caused by inhaled human neutrophil elastase (HNE), a model of abnormal MCC.
METHODS: Study 1: TMV was measured initially and then for 6 h after metered-dose inhaler treatment with salmeterol (42 microg), albuterol (180 microg), ipratropium bromide (36 microg), or vehicle. After 6 h, the sheep in the albuterol and ipratropium treatment arms were administered a second dose of drug, whereas the salmeterol and vehicle treatment arms received vehicle. TMV was measured for another 6 h. Study 2: Six sheep inhaled HNE aerosol, which significantly reduced TMV by 2 h. At this point, the sheep were treated with either salmeterol, albuterol, ipratropium, or vehicle, and the effects on TMV were measured for another 6 h. This experiment was repeated in four sheep using only salmeterol and albuterol, but the posttreatment measurements were extended to 12 h.
RESULTS: Study 1: Only salmeterol and albuterol increased TMV (p < 0.05) during the initial 6-h period. From 6 to 12 h only, the salmeterol-treated sheep had TMV that remained at or above the initial TMV for the entire time, although both albuterol and ipratropium showed enhancement of TMV compared to vehicle. Study 2: Salmeterol and albuterol reversed the HNE-induced depression in TMV to a similar degree over the 6-h time course. However, the protection afforded by salmeterol was more prolonged than that seen with albuterol if the posttreatment interval was extended to 12 h. Ipratropium and vehicle had no effect.
CONCLUSION: We conclude that salmeterol and albuterol can stimulate normal MCC and reverse HNE-induced mucociliary dysfunction and that salmeterol has a longer duration of action in these models of normal and abnormal MCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304342     DOI: 10.1378/chest.128.5.3743

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition.

Authors:  Annika B M Åstrand; Martin Hemmerling; James Root; Cecilia Wingren; Jelena Pesic; Edvin Johansson; Alaina L Garland; Arunava Ghosh; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.

Authors:  Michael D Kim; Nathalie Baumlin; Makoto Yoshida; Deepika Polineni; Sebastian F Salathe; Joseph K David; Charles A Peloquin; Adam Wanner; John S Dennis; Juliette Sailland; Philip Whitney; Frank T Horrigan; Juan R Sabater; William M Abraham; Matthias Salathe
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

3.  Electronic Cigarette Vapor with Nicotine Causes Airway Mucociliary Dysfunction Preferentially via TRPA1 Receptors.

Authors:  Samuel Chung; Nathalie Baumlin; John S Dennis; Robert Moore; Sebastian F Salathe; Phillip L Whitney; Juan Sabater; William M Abraham; Michael D Kim; Matthias Salathe
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

4.  Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion.

Authors:  Robert Tarran; Juan R Sabater; Tainya C Clarke; Chong D Tan; Catrin M Davies; Jia Liu; Arthur Yeung; Alaina L Garland; M Jackson Stutts; William M Abraham; Gary Phillips; William R Baker; Clifford D Wright; Sibylle Wilbert
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-29       Impact factor: 5.464

5.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

6.  Chronic β2AR stimulation limits CFTR activation in human airway epithelia.

Authors:  John J Brewington; Jessica Backstrom; Amanda Feldman; Elizabeth L Kramer; Jessica D Moncivaiz; Alicia J Ostmann; Xiaoting Zhu; L Jason Lu; John P Clancy
Journal:  JCI Insight       Date:  2018-02-22

Review 7.  Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases.

Authors:  Erol A Gaillard; Pradeep Kota; Martina Gentzsch; Nikolay V Dokholyan; M Jackson Stutts; Robert Tarran
Journal:  Pflugers Arch       Date:  2010-04-18       Impact factor: 3.657

8.  Airway drug pharmacokinetics via analysis of exhaled breath condensate.

Authors:  Charles R Esther; Richard C Boucher; M Ross Johnson; John H Ansede; Karl H Donn; Thomas G O'Riordan; Andrew J Ghio; Andrew J Hirsh
Journal:  Pulm Pharmacol Ther       Date:  2013-08-07       Impact factor: 3.410

9.  Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep.

Authors:  Juan R Sabater; Marvin A Sackner; Jose A Adams; William M Abraham
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

10.  Perseverant, non-indicated treatment of obese patients for obstructive lung disease.

Authors:  Spyridon Fortis; Joseph Kittah; Manuel De Aguirre; Maria Plataki; Armand Wolff; Yaw Amoateng-Adjepong; Constantine A Manthous
Journal:  BMC Pulm Med       Date:  2013-11-22       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.